Skip to main content

and
  1. No Access

    Article

    Working group report: Heavy-ion physics and quark-gluon plasma

    This is the report of Heavy Ion Physics and Quark-Gluon Plasma at WHEPP-09 which was part of Working Group-4. Discussion and work on some aspects of quark-gluon plasma believed to have created in heavy-ion col...

    Munshi G Mustafa, Sudhir Raniwala, T Awes, B Rai, RS Bhalerao, JG Contreras in Pramana (2006)

  2. No Access

    Article

    Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experience

    To elucidate the clinical and biological features of childhood acute myeloid leukemia (AML) with the t(8;21), we reviewed the records of patients with AML treated at St Jude Children's Research Hospital over a...

    JE Rubnitz, SC Raimondi, AR Halbert, X Tong, DK Srivastava, BI Razzouk, C-H Pui in Leukemia (2002)

  3. No Access

    Article

    Effect of extended immunosuppressive drug treatment on B cell vs T cell reconstitution in pediatric bone marrow transplant recipients

    Allogeneic bone marrow transplantation (BMT) is an effective therapy for a variety of malignancies and blood disorders, but rarely serves as a frontline treatment because of numerous, potential complications. ...

    S D'Costa, KS Slobod, E Benaim, L Bowman, J Cunningham in Bone Marrow Transplantation (2001)

  4. No Access

    Article

    Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience

    To identify treatment factors that may affect the survival of children with inv(16)(p13.1q22), we compared the outcomes of 19 patients with this genetic feature treated at our institution during two treatment ...

    BI Razzouk, SC Raimondi, DK Srivastava, M Pritchard, FG Behm, X Tong in Leukemia (2001)

  5. No Access

    Article

    Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation

    Twenty-three children with de novo acute myelogenous leukemia (AML) (n= 20), secondary AML (n = 1), or non-Hodgkin's lymphoma (NHL) (n = 2) underwent allogeneic bone marrow transplantation (alloBMT) for graft fai...

    GA Hale, **n Tong, E Benaim, JM Cunningham, HE Heslop in Bone Marrow Transplantation (2001)

  6. No Access

    Article

    Second malignancy after treatment of childhood acute myeloid leukemia

    To investigate the cumulative incidence of second malignancy and the competing risk of death due to any other cause in patients who were treated for childhood acute myeloid leukemia (AML), we analyzed the outc...

    W Leung, RC Ribeiro, M Hudson, X Tong, DK Srivastava, JE Rubnitz, JT Sandlund in Leukemia (2001)

  7. No Access

    Article

    Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects

    The purpose of this study was to assess the feasibility and efficacy of a treatment regimen for pediatric acute myelogenous leukemia (AML) that uses four rotating drug pairs and adjusts dosages of etoposide an...

    MK Arnaout, KM Radomski, DK Srivastava, X Tong, JR Belt, SC Raimondi, FG Behm in Leukemia (2000)

  8. No Access

    Article

    Prognostic factors in infants with acute myeloid leukemia

    Little is known about the factors that affect treatment outcome in very young children with acute myeloid leukemia (AML). We therefore analyzed the prognostic impact of various presenting clinical and laborato...

    C-H Pui, SC Raimondi, DK Srivastava, X Tong, FG Behm, B Razzouk, JE Rubnitz in Leukemia (2000)

  9. No Access

    Article

    Adenovirus infection after pediatric bone marrow transplantation

    Retrospective analysis of 206 patients undergoing 215 consecutive bone marrow transplants (BMT) at St Jude Children’s Research Hospital between November 1990 and December 1994 identified 6% (seven male, six fe...

    GA Hale, HE Heslop, RA Krance, MA Brenner, D Jayawardene in Bone Marrow Transplantation (1999)